ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,310
Screening encounters
3,825
Diagnostic referrals
727
Outstanding pathways
279

Screening pathway

  1. Screening3,825Encounters
  2. Positive finding1,322Documented findings
  3. Referral727Diagnostic referrals
  4. Follow-up848Diagnostic visits
  5. Outcome448Resolved pathways

Stage totals use different units. Pending pathways: 279. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 3232 · EXP-3232Synthetic · Site B

Full participant history through 2026-08-14, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-03-20
  4. · Diagnostic referral · EXP-3232-T-R
  5. · Contact attempt · Unsuccessful
  6. · Diagnostic booking · Initial booking
  7. · Contact attempt · Unsuccessful
  8. · Contact attempt · Reached
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-3232-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-02-20

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

3310 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4289 · Expanded synthetic participant 4289Site A — Urban Referral Hub
EXP-4290 · Expanded synthetic participant 4290Site C — Rural Outreach Programme
EXP-4292 · Expanded synthetic participant 4292Site C — Rural Outreach Programme
EXP-4294 · Expanded synthetic participant 4294Site D — Community Engagement Programme
EXP-4295 · Expanded synthetic participant 4295Site D — Community Engagement Programme
EXP-4297 · Expanded synthetic participant 4297Site C — Rural Outreach Programme
EXP-4299 · Expanded synthetic participant 4299Site B — Peri-Urban Access Programme
EXP-4300 · Expanded synthetic participant 4300Site B — Peri-Urban Access Programme
EXP-4301 · Expanded synthetic participant 4301Site E — Resource-Constrained Navigation Programme
EXP-4302 · Expanded synthetic participant 4302Site D — Community Engagement Programme
EXP-4303 · Expanded synthetic participant 4303Site D — Community Engagement Programme
EXP-4304 · Expanded synthetic participant 4304Site D — Community Engagement Programme
EXP-4306 · Expanded synthetic participant 4306Site D — Community Engagement Programme
EXP-4308 · Expanded synthetic participant 4308Site A — Urban Referral Hub
EXP-4309 · Expanded synthetic participant 4309Site D — Community Engagement Programme
EXP-4310 · Expanded synthetic participant 4310Site E — Resource-Constrained Navigation Programme
EXP-4312 · Expanded synthetic participant 4312Site E — Resource-Constrained Navigation Programme
EXP-4313 · Expanded synthetic participant 4313Site A — Urban Referral Hub
EXP-4316 · Expanded synthetic participant 4316Site C — Rural Outreach Programme
EXP-4317 · Expanded synthetic participant 4317Site E — Resource-Constrained Navigation Programme
EXP-4318 · Expanded synthetic participant 4318Site B — Peri-Urban Access Programme
EXP-4319 · Expanded synthetic participant 4319Site E — Resource-Constrained Navigation Programme
EXP-4320 · Expanded synthetic participant 4320Site D — Community Engagement Programme
EXP-4321 · Expanded synthetic participant 4321Site C — Rural Outreach Programme
EXP-4322 · Expanded synthetic participant 4322Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1512
HPV DNA
1766
Cytology
547

Navigation activity

Barrier documented
632
Contact attempt
1072
Navigation intervention
270
Diagnostic booking
897
Diagnostic visit
848

Documented barriers

Contact difficulty
210
Transport difficulty
198
Appointment coordination
224

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.